Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1699* | 2021 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 445* | 2021 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 219 | 2022 |
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 111 | 2021 |
Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus H Iqbal, S Straw, TP Craven, K Stirling, SB Wheatcroft, KK Witte ESC heart failure 7 (5), 2032-2041, 2020 | 84 | 2020 |
Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery S Straw, MW Baig, R Gillott, J Wu, KK Witte, DJ O’regan, JAT Sandoe Clinical Infectious Diseases 71 (3), 564-571, 2020 | 77 | 2020 |
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study M Drozd, M Pujades-Rodriguez, PJ Lillie, S Straw, AW Morgan, ... The Lancet Infectious Diseases 21 (8), 1184-1191, 2021 | 66 | 2021 |
Predicting one‐year mortality in heart failure using the ‘Surprise Question’: a prospective pilot study S Straw, R Byrom, J Gierula, MF Paton, A Koshy, R Cubbon, M Drozd, ... European journal of heart failure 21 (2), 227-234, 2019 | 58 | 2019 |
Infection-related hospitalization in heart failure with reduced ejection fraction: a prospective observational cohort study M Drozd, E Garland, AMN Walker, TA Slater, A Koshy, S Straw, J Gierula, ... Circulation: Heart Failure 13 (5), e006746, 2020 | 51 | 2020 |
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 45 | 2022 |
Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction S Straw, M McGinlay, KK Witte Open Heart 8 (1), e001585, 2021 | 45 | 2021 |
Dying ‘due to’or ‘with’COVID-19: a cause of death analysis in hospitalised patients TA Slater, S Straw, M Drozd, S Kamalathasan, A Cowley, KK Witte Clinical medicine 20 (5), e189, 2020 | 43 | 2020 |
Prioritizing symptom management in the treatment of chronic heart failure AO Koshy, ER Gallivan, M McGinlay, S Straw, M Drozd, AG Toms, ... ESC Heart Failure 7 (5), 2193-2207, 2020 | 42 | 2020 |
Empagliflozin treatment is associated with improvements in cardiac energetics and function and reductions in myocardial cellular volume in patients with type 2 diabetes S Thirunavukarasu, N Jex, A Chowdhary, IU Hassan, S Straw, TP Craven, ... Diabetes 70 (12), 2810-2822, 2021 | 40 | 2021 |
Association of heart failure and its comorbidities with loss of life expectancy M Drozd, SD Relton, AMN Walker, TA Slater, J Gierula, MF Paton, J Lowry, ... Heart 107 (17), 1417-1421, 2021 | 32 | 2021 |
Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data S Straw, M McGinlay, M Drozd, TA Slater, A Cowley, S Kamalathasan, ... BMC Palliative Care 20, 1-11, 2021 | 25 | 2021 |
Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence N Wood, S Straw, M Scalabrin, LD Roberts, KK Witte, TS Bowen ESC heart failure 8 (1), 3-15, 2021 | 19 | 2021 |
To the editor—New phones, old problem? Interference with cardiovascular implantable electronic devices by phones containing magnets Z Patterson, S Straw, M Drozd, MF Paton, C Cole, KK Witte, J Gierula Heart Rhythm 18 (6), 1041, 2021 | 15 | 2021 |
Personalized rate-response programming improves exercise tolerance after 6 months in people with cardiac implantable electronic devices and heart failure: a phase II study J Gierula, JE Lowry, MF Paton, CA Cole, R Byrom, AO Koshy, H Chumun, ... Circulation 141 (21), 1693-1703, 2020 | 13 | 2020 |
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction S Straw, CA Cole, M McGinlay, M Drozd, TA Slater, JE Lowry, MF Paton, ... Clinical Research in Cardiology 112 (1), 111-122, 2023 | 10 | 2023 |